Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$258,830,975
+$92,435,100 QoQ
Shares Held
5,399,061
+19.2% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#15
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 1%
None 1%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2024CallValue
$5,424,120
CallShares
38,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. NVO ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,358,401 | $5,227,597,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,211,475 | $3,355,318,297 | |
| 3 | ABBV |
AbbVie Inc.
|
8,163,806 | $2,054,340,133 | |
| 4 | AZN |
Astrazeneca PLC
|
10,427,503 | $1,977,263,112 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,293,086 | $1,836,661,547 | |
| 6 | AMGN |
Amgen Inc
|
4,328,785 | $1,567,539,618 | |
| 7 | PFE |
Pfizer Inc
|
32,814,260 | $790,167,373 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,094,886 | $696,907,326 |
All Filings in NVO
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,830,975 | 5,399,061 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $166,395,875 | 4,527,779 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $223,180,176 | 4,386,403 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $262,893,024 | 4,737,665 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $351,194,046 | 5,088,294 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $378,190,093 | 5,446,286 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $469,732,247 | 5,460,733 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $714,910,559 | 6,004,120 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $842,449,759 | 5,901,988 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $5,424,120 | 38,000 | Call | Sole | 2024-11-06 | |
| 2024-03-31 | $705,783,594 | 5,496,757 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $390,494,675 | 3,774,719 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,210,365 | 11,700 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $331,299,962 | 3,643,061 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,513,352 | 114,400 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $263,334,950 | 1,627,232 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $251,627,709 | 1,581,172 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $234,667,781 | 1,733,913 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $172,437,907 | 1,730,783 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $203,510,177 | 1,826,350 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $201,508,660 | 1,814,576 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $200,839,072 | 1,793,206 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $162,626,726 | 1,693,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $136,630,793 | 1,631,023 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $105,634,729 | 1,566,816 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $103,272,312 | 1,478,487 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $98,199,426 | 1,414,366 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $93,142,347 | 1,422,455 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $82,507,586 | 1,370,558 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||